Kempczinski Christopher J 4

What Happened
Christopher J. Kempczinski, a director of Procter & Gamble Co. (PG), received a grant of 258 restricted stock units (RSUs) on June 9, 2026. The RSUs were issued at $0.00 per share (total $0 reported) as an award rather than a purchase — this is a compensation grant, not an open‑market transaction or sale. Footnotes indicate the award was made under The Procter & Gamble 2025 Stock and Incentive Compensation Plan and includes dividend equivalents.

Key Details

• Transaction date and type: 2026-06-09 — Grant/Award (code A) of 258 RSUs at $0.00.
• Filing date: Form 4 filed 2026-06-10 (one day after the grant), which is within the typical 2‑business‑day reporting window.
• Shares owned after the transaction: Not specified in the provided filing excerpt.
• Footnotes: F1 — RSUs awarded pursuant to the 2025 Stock and Incentive Compensation Plan. F2 — total includes dividend equivalents credited as additional RSUs.
• No indication in this filing of tax withholding, a 10b5‑1 plan, or immediate sale of underlying shares.

Context
RSUs are a form of deferred equity compensation: they represent the right to receive shares (or cash equivalent) in the future, usually subject to vesting. Grants are common for directors and employees and are part of routine compensation; they do not by themselves indicate buying or selling sentiment. The inclusion of dividend equivalents means the award also credits value equivalent to dividends, typically as additional RSUs.